FORBES-TATE

Lobbying for ANTIMICROBIAL INNOVATION ALLIANCE · Development of antimicrobial resistance policy to assist life sciences industry.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · posted Jul 18, 2025

Lobbying activity 1

Health Issues

Issues related to the development of critical need antimicrobial biopharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.